Hasil Pencarian - Lukas Donix

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target.

    PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target. oleh Holger Hans Hermann Erb, Marlies Ebert, Ronja Kuhn, Lukas Donix, Axel Haferkamp, Robert Ian Seed, Eva Jüngel

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines

    Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines oleh Dinah Linke, Lukas Donix, Claudia Peitzsch, Holger H. H. Erb, Anna Dubrovska, Manuel Pfeifer, Christian Thomas, Susanne Fuessel, Kati Erdmann

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.

    Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. oleh Holger H H Erb, Julia Bodenbender, Florian Handle, Tamara Diehl, Lukas Donix, Igor Tsaur, Martin Gleave, Axel Haferkamp, Johannes Huber, Susanne Fuessel, Eva Juengel, Zoran Culig, Christian Thomas

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: